Latest Breaking News On - Capsida biotherapeutics - Page 9 : comparemela.com

Capsida and Prevail Collaborate to Develop Non-Invasive Gene Therapies for CNS Diseases

Prevail, Capsida partner to develop gene therapies for nervous system diseases

BioPharma

Eli Lilly Turns to Startup Capsida to Bring Gene Therapy Into the Brain

Eli Lilly is paying $55 million up front to begin an alliance with Capsida Biotherapeutics pursuing gene therapies for central nervous system disorders. Capsida’s technology enables the delivery of a gene therapy to a single organ or multiple organs, a capability that could bring such treatments to a wider range of diseases.

Dantari Raises $47M in Round - San Fernando Valley Business Journal

Oncology company exits from stealth with funding.

19-acre biotech campus in Thousand Oaks approved

A 19-acre campus approved by planning commissioners aims at attracting more biotech firms to Thousand Oaks.